Diagnosis and treatment of dorsalgia in outpatient practice

Author:

Maksimov Yu. N.1ORCID,Alekseeva O. A.1ORCID

Affiliation:

1. Kazan State Medical Academy

Abstract

Dorsalgia − nonspecific back pain is the leader in the number of requests for medical help. Nonspecific musculoskeletal pain accounts for up to 80–90% of all pain syndromes. Back pain can be provoked by professional static-dynamic overloads, violations of the statics of the musculoskeletal system, exposure to cold and/or vibration, overweight, hereditary factors, etc. In outpatient practice, doctors often have to deal with various forms and clinical manifestations of dorsalgia. The leading role in the diagnosis is given to the physical examination of the patient. With the active collection of complaints and anamnesis, the doctor has the opportunity to identify the leading problem that prompted the patient to seek medical help, clarify the localization of the process, the time of occurrence and the sequence of symptoms, which allows you to fully imagine the picture of the disease and differentiate between simultaneously occurring nosologies. The identification of the affected structure, which is the root cause of musculoskeletal pain, does not affect the appointment of basic drug therapy, but it is absolutely necessary when conducting local injection therapy, as well as a number of non-drug treatment methods. Among the pharmacological drugs used to treat musculoskeletal pain, the priority remains for NSAIDs, the choice of which, first of all, is dictated by its safety. The favorable safety profile of Nimesil® (nimesulide) has been confirmed by numerous domestic and foreign studies. Nimesulide is registered in 50 countries for the treatment of pain syndromes, and is also used as an antipyretic and anti-inflammatory drug. According to the results of a study in the Russian Federation, Nimesil® (nimesulide) turned out to be the most frequently prescribed drug, which is due to its high effectiveness and ability to accumulate in therapeutic concentration in the focus of inflammation. In addition to pharmacotherapy, the treatment regimen for musculoskeletal pain should include, on a parity basis, non-drug treatment methods that allow correction of pathobiomechanical changes. If ignored, in many cases, drug anesthesia does not lead to the desired effect, which can contribute to the chronization of pain. The described clinical case illustrates the simultaneous course of two variants of dorsalgia in the patient, different in localization, clinical manifestations, severity and duration of the course.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference40 articles.

1. Kukushkin ML. Back pain: targets for pathogenetic therapy. RMJ. 2011;19(30):1862–1866. (In Russ.) Available at: https://www.rmj.ru/articles/nevrologiya/Boly_v_spine_misheni_dlya_patogeneticheskoy_terapii/.

2. Кукушкин МЛ, Табеева ГР, Подчуфарова ЕВ. Болевой синдром: патофизиология, клиника, лечение: клинические рекомендации. М.: ИМА-Пресс. 2014; 64 с.

3. Sadokha KA, Golovko AM, Varikash MS. Some aspects of secondary dorsalgia. Meditsinskie Novosti. 2019;(2):29–34. (In Russ.) Available at: https://www.mednovosti.by/journal.aspx?article=8597.

4. Merkulov YuA, Gamburg AM, Lezina DS, Fedorova AN, Onsin AA, Merkulova DM. Optimizing the diagnosis and treatment of dorsalgia in real-world clinical practice: the secondary endpoint of the DORISS multicenter observational study. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;123(2):73–82. (In Russ.) https://doi.org/10.17116/jnevro202312302173.

5. Klimycheva MB. An integrated approach to the treatment of vertebrogenic pain. Lechaschi Vrach. 2023;10(26):32–37. (In Russ.) https://doi.org/10.51793/OS.2023.26.10.005.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3